2018
Clemente says he started working on Levels full-time in late 2017 or early 2018.
“it was actually late 2017, early 2018 when I, when I went full, full bore on it.”
Topic
Levels
9 facts from 1 episode, in date order. These are what speakers said on the shows, each linked to the moment it was said. They aren't independently verified.
2018
Clemente says CGMs were Class III regulated, prescription-only medical devices when Levels began.
“these were class three regulated medical devices, prescription only.”
2020
Clemente says COVID-era changes eased telehealth rules, including looser licensing and wider choice of video platforms.
“we saw a huge number of, I think, improvements where physicians could be licensed across many states.”
Undated
The Levels beta one-month program was priced at $399.
“So the price to participate in the program is $395, right? $399. Yep.”
Undated
Clemente says about 7,000 people had completed the Levels beta program.
“thus far we've had about 7,000 people go through the, through the beta program.”
Undated
Clemente says Levels had about 105,000 people on its waitlist.
“we actually have, uh, about 105,000 people on a wait list right now and trying to get in.”
Undated
Clemente says the one-month Levels program has gross margins of roughly 50% to 60%.
“We have pretty good margins on the order of 50% to 60%, depending on the specific for the one-month program.”
Undated
Clemente claims Levels has the largest dataset of non-diabetic glucose paired with lifestyle information, by nearly an order of magnitude.
“we currently do have by coming up on an order of magnitude, the largest data set ever in non-diabetic glucose”
Undated
Clemente says more than 70% of Levels users who ate oatmeal exceeded the prediabetes glucose threshold.
“something like 70 plus percent of people that were eating oatmeal while using levels had, you know, exceeded that, that prediabetes threshold”
Episodes